Guggenheim Capital’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Sell |
|
|||||
|
2025
Q1 | $2.36M | Buy |
|
|||||
|
2024
Q4 | $844K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $211K | Sell |
|
|||||
|
2021
Q3 | $2.64M | Sell |
|
|||||
|
2021
Q2 | $2.95M | Buy |
|
|||||
|
2021
Q1 | $2.76M | Sell |
|
|||||
|
2020
Q4 | $2.84M | Buy |
|
|||||
|
2020
Q3 | $1.89M | Sell |
|
|||||
|
2020
Q2 | $3.1M | Buy |
|
|||||
|
2020
Q1 | $1.72M | Sell |
|
|||||
|
2019
Q4 | $2.81M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $938K | Buy |
|
|||||
|
2017
Q4 | $491K | Sell |
|
|||||
|
2017
Q3 | $1.94M | Sell |
|
|||||
|
2017
Q2 | $938K | Buy |
|
|||||
|
2017
Q1 | $735K | Sell |
|
|||||
|
2016
Q4 | $670K | Buy |
|